Study participants were 134 individuals from the HYPOAGE cohort with insulin-treated T2D aged ≥ 75 years and using a continuous glycaemic-monitoring (CGM) device for 28 days. "Diabetes overtreatment" ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback